Ministers met on Tuesday to agree on a plan to ease most Covid-19 restrictions by 22 October.View More Covid-19: Irish Cabinet agrees to end most restrictions by 22 October
Citing recent research that overconsumption of ultra processed foods (UPF) and beverages lead to overweight and obesity — key risk factors for cancer, cardiovascular disease, non alcoholic fatty liver and various other deadly diseases; BPNI, Nutrition Advocacy in Public Interest (NAPi) and several public health organisations called upon the Centre to urgently consider application of mandatory warning labels on ultra-processed foods and food products high in sugar/salt or saturated fat.
The webinar was chaired by Suneela Garg, President, Indian Association of Preventive and Social Medicine (IAPSM).
“Right-to-health is a fundamental right of every human being & youths health is Nations wealth. Therefore in Indian context, states are required to adopt regulatory measures such as front-of-package warning labelling on foods and beverages containing excessive amounts of critical nutrients such as sugar to tackle the rising burden of obesity and NCDs,” she said.
Experts from the Paediatric and Adolescent Nutrition Society (PAN) – IAP Nutrition Chapter and Epidemiology Foundation
“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine. While the Centre for Adverse Reactions Monitoring has received other reports of deaths in someone recently vaccinated, none are considered related to vaccination,” it said in a statement.
After donating or selling 66 million doses to nearly 100 countries, India barred exports in the middle of April to focus on domestic immunisation as infections exploded, upsetting the inoculation plans of many African and South Asian countries.
India’s daily vaccinations surpassed 10 million doses on Friday, with national vaccine production more than doubling since April and set to rise again in the coming weeks. New production lines have been set up, a vaccine developed by Cadila Healthcare won recent approval, and commercial production of Russia’s Sputnik V is starting in India.
The Serum Institute of India (SII), the world’s biggest vaccine maker, is now producing about 150 million doses a month of its version of the AstraZeneca shot, more than twice its April output of about 65 million, a source with knowledge of the matter said.
“No fixed timeline on exports but the company hopes to restart in a few months,” said the source, who declined to be named without
Doctors call for more guidance after the NHS in England and Wales stops all non-urgent blood tests.View More NHS blood test tube shortage: Doctors 'facing difficult choices'
TOKYO: Japan is looking into the possibility of mixing shots of AstraZeneca Plc’s Covid-19 vaccine with those developed by other drug makers in a bid to speed up its vaccine rollout, the minister in charge of vaccinations said on Sunday.
Japan, which has previously relied on the Pfizer Inc /BioNTech SE and Moderna Inc vaccines, approved AstraZeneca’s vaccine in July and has secured two million doses.
“I have asked the health ministry to come up with an opinion about the use of AstraZeneca vaccines for the first dose and Pfizer’s with the second, or the AstraZeneca’s as the first shot and Moderna as second,” vaccine programme chief Taro Kono said on the Fuji Television network.
This could speed up the vaccination rollout by shortening the intervals between the first and second shots when using the AstraZeneca vaccine, he said.
AstraZeneca’s two shots are administered with an interval of eight weeks, longer than for the other vaccines.
Japan is battling its worst wave of infections, driven by the Delta variant, with new daily infections exceeding 25,000 this month for the first time.
The country’s vaccination ratio has lagged other developed nations. Japan has inoculated 54% of its